vigabatrin has been researched along with Atrophy in 5 studies
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe the clinical pattern of retinal atrophy in children caused by the anticonvulsant vigabatrin." | 7.72 | Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children. ( Buncic, JR; Logan, WJ; MacKeen, LD; Munn, JR; Panton, CM; Westall, CA, 2004) |
| "To describe the clinical pattern of retinal atrophy in children caused by the anticonvulsant vigabatrin." | 3.72 | Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children. ( Buncic, JR; Logan, WJ; MacKeen, LD; Munn, JR; Panton, CM; Westall, CA, 2004) |
| "Seizures in a term infant with Ohtahara syndrome, associated with polymicrogyria, and a pre-term neonate with similar clinical features, failed to respond to conventional anticonvulsants, but were controlled with vigabatrin monotherapy." | 3.69 | Vigabatrin monotherapy in resistant neonatal seizures. ( Barwick, DD; Baxter, PS; Gardner-Medwin, D; Ince, P; Livingston, J; Murdoch-Eaton, D, 1995) |
| "EEG showed typical hypsarrhythmia in 8 cases, asymmetrical hypsarrhythmia in 1 case and modified hypsarrhythmia in another case." | 1.30 | [West's syndrome in patients with cerebral paralysis and periventricular leukomalacia: a good response to treatment]. ( Caraballo, R; Cersósimo, R; Fejerman, N; Intruvini, S; Pociecha, J, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kölker, S | 1 |
| Hoffmann, GF | 1 |
| Schor, DS | 1 |
| Feyh, P | 1 |
| Wagner, L | 1 |
| Jeffrey, I | 1 |
| Pourfarzam, M | 1 |
| Okun, JG | 1 |
| Zschocke, J | 1 |
| Baric, I | 1 |
| Bain, MD | 1 |
| Jakobs, C | 1 |
| Chalmers, RA | 1 |
| Buncic, JR | 1 |
| Westall, CA | 1 |
| Panton, CM | 1 |
| Munn, JR | 1 |
| MacKeen, LD | 1 |
| Logan, WJ | 1 |
| Rebolleda, G | 1 |
| García Pérez, JL | 1 |
| Muñoz Negrete, FJ | 1 |
| Tang, RA | 1 |
| Baxter, PS | 1 |
| Gardner-Medwin, D | 1 |
| Barwick, DD | 1 |
| Ince, P | 1 |
| Livingston, J | 1 |
| Murdoch-Eaton, D | 1 |
| Caraballo, R | 1 |
| Cersósimo, R | 1 |
| Intruvini, S | 1 |
| Pociecha, J | 1 |
| Fejerman, N | 1 |
5 other studies available for vigabatrin and Atrophy
| Article | Year |
|---|---|
Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen.
Topics: Acidosis; Acute Disease; Adolescent; Anticonvulsants; Atrophy; Brain; Carnitine; DNA Mutational Anal | 2003 |
Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children.
Topics: Adolescent; Anticonvulsants; Atrophy; Child; Electroretinography; Female; Humans; Infant; Male; Opti | 2004 |
Vigabatrin toxicity in children.
Topics: Anticonvulsants; Atrophy; Child; Diagnostic Techniques, Ophthalmological; Humans; Optic Atrophy; Ret | 2005 |
Vigabatrin monotherapy in resistant neonatal seizures.
Topics: Agenesis of Corpus Callosum; Anticonvulsants; Atrophy; Brain; Cerebral Cortex; Dose-Response Relatio | 1995 |
[West's syndrome in patients with cerebral paralysis and periventricular leukomalacia: a good response to treatment].
Topics: Anticonvulsants; Atrophy; Cerebral Palsy; Cerebral Ventricles; Child; Child, Preschool; Female; gamm | 1997 |